ADRA2A Antikörper
(1 reference)-
- Target Alle ADRA2A Antikörper anzeigen
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADRA2A Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (IF)
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of ADRA2A.
- Sequenz
- C-TERRPNGLGP ERS
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human ADRA2A.
- Top Product
- Discover our top product ADRA2A Primärantikörper
-
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 385-450) antibody
ADRA2A Reaktivität: Ratte WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (Internal Region) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 240-380) antibodyADRA2A Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 7-20), (Extracellular), (N-Term) antibodyADRA2A Reaktivität: Ratte, Maus WB, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (Internal Region) antibodyVerified ADRA2A Reaktivität: Human ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 331-380) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (C-Term) antibodyADRA2A Reaktivität: Human WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 218-374) antibodyADRA2A Reaktivität: Human ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (C-Term) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 223-256) antibodyADRA2A Reaktivität: Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal RB52053 unconjugated
-
- Applikationshinweise
-
ELISA (1:32000)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons." in: The Journal of biological chemistry, Vol. 284, Issue 10, pp. 6270-81, (2009) (PubMed).
-
: "p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons." in: The Journal of biological chemistry, Vol. 284, Issue 10, pp. 6270-81, (2009) (PubMed).
-
- Target
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Andere Bezeichnung
- Alpha-2A adrenergic receptor (ADRA2A Produkte)
- Synonyme
- ADRA2A antikoerper, AW122659 antikoerper, Adra-2 antikoerper, Adra-2a antikoerper, alpha(2A)AR antikoerper, alpha2-C10 antikoerper, alpha2A antikoerper, alpha2A-AR antikoerper, ADRA2 antikoerper, ADRA2R antikoerper, ADRAR antikoerper, ALPHA2AAR antikoerper, ZNF32 antikoerper, CA2-47 antikoerper, RATRG20 antikoerper, RG20 antikoerper, PORA2AR antikoerper, adrenoceptor alpha 2A antikoerper, alpha-2A adrenergic receptor-like antikoerper, adrenergic receptor, alpha 2a antikoerper, adra2a antikoerper, ADRA2A antikoerper, LOC100414445 antikoerper, Adra2a antikoerper
- Gen-ID
- 150
- Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
-
